# Fecal Microbiota Transplantation as the First-line Treatment in Active Pediatric Crohn's Disease

> **NCT05321758** · NA · RECRUITING · sponsor: **Tongji Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Crohn Disease

## Interventions

- **BIOLOGICAL:** Fecal Microbiota Transplantation
- **DRUG:** Immunosuppressive Agents

## Key facts

- **NCT ID:** NCT05321758
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-03-22
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05321758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05321758, "Fecal Microbiota Transplantation as the First-line Treatment in Active Pediatric Crohn's Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05321758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*